phenoxybenzamine has been researched along with Adenoma, Prostatic in 40 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective study was conducted in a community hospital in order to evaluate the therapeutic effect of dibenyline, finasteride, and a combination of the two drugs for symptomatic benign prostatic hyperplasia (BPH)." | 9.08 | Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia. ( Kuo, HC, 1998) |
| "Nine patients with bladder outlet obstruction attributable to benign prostatic hyperplasia were treated with 15 mg of phenoxybenzamine daily." | 7.66 | Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation. ( Blaabjerg, J; Clausen, S; Gerstenberg, T; Nielsen, ML, 1980) |
| "A prospective study was conducted in a community hospital in order to evaluate the therapeutic effect of dibenyline, finasteride, and a combination of the two drugs for symptomatic benign prostatic hyperplasia (BPH)." | 5.08 | Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia. ( Kuo, HC, 1998) |
| "Nine patients with bladder outlet obstruction attributable to benign prostatic hyperplasia were treated with 15 mg of phenoxybenzamine daily." | 3.66 | Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation. ( Blaabjerg, J; Clausen, S; Gerstenberg, T; Nielsen, ML, 1980) |
| "Medical management of benign prostatic hyperplasia (BPH) is an alternative to surgical treatment of this disease." | 1.29 | Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate. ( Breslin, D; Chou, TC; Felsen, D; Fields, DW; Kane, M; Marion, DN; Vaughan, ED, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (75.00) | 18.7374 |
| 1990's | 8 (20.00) | 18.2507 |
| 2000's | 2 (5.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Te, AE | 1 |
| Bouffioux, CR | 1 |
| Penders, L | 1 |
| Gerstenberg, T | 1 |
| Blaabjerg, J | 1 |
| Nielsen, ML | 1 |
| Clausen, S | 1 |
| Caine, M | 10 |
| Perlberg, S | 4 |
| Shapiro, A | 1 |
| Lardennois, B | 1 |
| El Khansa, A | 1 |
| Amory, JP | 1 |
| Coulon, JM | 1 |
| Lemaire, P | 1 |
| Flamm, J | 1 |
| Abrams, PH | 2 |
| Shah, PJ | 2 |
| Stone, R | 2 |
| Choa, RG | 2 |
| Abrams, P | 1 |
| Hollister, P | 1 |
| Lawrence, J | 1 |
| Doyle, PT | 1 |
| Sherwood, T | 1 |
| Whitaker, RH | 1 |
| Wu, JP | 1 |
| Gu, FL | 1 |
| Lu, EX | 1 |
| Brooks, ME | 2 |
| Sidi, AA | 1 |
| Hanani, Y | 1 |
| Braf, ZF | 1 |
| Braf, ZE | 1 |
| Griffiths, DJ | 1 |
| Schröder, FH | 1 |
| Reuther, K | 1 |
| Aagaard, J | 1 |
| Vela-Navarrete, R | 1 |
| Breslin, D | 1 |
| Fields, DW | 1 |
| Chou, TC | 1 |
| Marion, DN | 1 |
| Kane, M | 1 |
| Vaughan, ED | 1 |
| Felsen, D | 1 |
| Brawer, MK | 1 |
| Lepor, H | 1 |
| Gómez Sancha, F | 1 |
| Fernández Arjona, M | 1 |
| Peinado Ibarra, F | 1 |
| Fernández Borrell, A | 1 |
| Mínguez Martínez, R | 1 |
| Pereira Sanz, I | 1 |
| Kuo, HC | 1 |
| Altwein, JE | 1 |
| Meretyk, S | 2 |
| Pfau, A | 1 |
| Boreham, PF | 1 |
| Braithwaite, P | 1 |
| Milewski, P | 1 |
| Pearson, H | 1 |
| Kondo, A | 1 |
| Narita, H | 1 |
| Otani, T | 1 |
| Kobayashi, M | 1 |
| Takita, T | 1 |
| Bellows, JG | 1 |
| Perrigot, M | 1 |
| Vannier, A | 1 |
| Bor, Y | 1 |
| Goodwin, MI | 1 |
| Chester, JF | 1 |
| Jenkins, JD | 1 |
| Ferrie, BG | 1 |
| Paterson, PJ | 1 |
| Chen, KK | 1 |
| Chang, LS | 1 |
| Chen, MT | 1 |
| Huang, JK | 1 |
| Yin, JH | 1 |
| Lin, SN | 1 |
| Lin, AD | 1 |
| Staub, WR | 1 |
| Staub, JS | 1 |
| Tachev, S | 1 |
| Petrov, P | 1 |
| Simeonov, P | 1 |
9 reviews available for phenoxybenzamine and Adenoma, Prostatic
| Article | Year |
|---|---|
A modern rationale for the use of phenoxybenzamine in urinary tract disorders and other conditions.
Topics: Adrenergic alpha-Antagonists; Animals; Clinical Trials as Topic; Half-Life; Humans; Male; Phenoxyben | 2002 |
Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Labetalol; Male | 1984 |
The role of alpha 1-blockade in benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aging; Clinical Trials as Topic; Humans; Male; Phenoxybenzamine; Prazo | 1993 |
Medical therapy for benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Anilides; Clinical | 1993 |
[Alpha blockers in the treatment of benign hyperplasia of the prostate].
Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prosta | 1997 |
Obstructive benign prostatic hyperplasia: therapeutical aspects.
Topics: Adrenergic alpha-Antagonists; Combined Modality Therapy; Costs and Cost Analysis; Enzyme Inhibitors; | 1998 |
Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Male; Phenoxybenzamine; Prostate; Pr | 1990 |
The place of pharmacologic treatment in benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; Urination Disor | 1985 |
Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Phenoxybenzamine; Prazosin; Prostate; Prostatic Hyperpla | 1988 |
13 trials available for phenoxybenzamine and Adenoma, Prostatic
| Article | Year |
|---|---|
Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Labetalol; Male | 1984 |
Bladder outflow obstruction treated with phenoxybenzamine.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Phenoxybenzamine; Pr | 1981 |
Bladder outflow obstruction treated with phenoxybenzamine.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Phenoxybenzamine; Pr | 1982 |
Bladder outflow obstruction treated with phenoxybenzamine. Preliminary note.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Humans; Male; Mid | 1982 |
Ineffectiveness of phenoxybenzamine in treatment of benign prostatic hypertrophy. A controlled study.
Topics: Adult; Aged; Clinical Trials as Topic; Humans; Male; Middle Aged; Phenoxybenzamine; Pressure; Prosta | 1983 |
Phenoxybenzamine in prostatic obstruction.
Topics: Aged; Double-Blind Method; Drug Evaluation; Humans; Male; Middle Aged; Phenoxybenzamine; Pressure; P | 1984 |
Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Follo | 1998 |
Alpha-adrenergic blockers in prostatism.
Topics: Chronic Disease; Clinical Trials as Topic; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; Ti | 1977 |
A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia | 1978 |
Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Male; Phenoxybenzamine; Prostate; Pr | 1990 |
Acute urinary retention secondary to benign prostatic hyperplasia. Effect of alpha-adrenergic blockade.
Topics: Adult; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Phenoxybenzamine; Prostatic Hyperplasia; | 1986 |
Phenoxybenzamine in prostatic hypertrophy. A double-blind study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Phenoxybenzam | 1987 |
Urodynamic and clinical effect of alpha-adrenergic blocker (phenoxybenzamine) in patients with benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; P | 1988 |
20 other studies available for phenoxybenzamine and Adenoma, Prostatic
| Article | Year |
|---|---|
Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
Topics: Aged; Cystoscopy; Humans; Male; Phenoxybenzamine; Pressure; Prostatic Hyperplasia; Urinary Bladder N | 1980 |
Phenoxybenzamine for benign prostatic obstruction. Review of 200 cases.
Topics: Adult; Age Factors; Aged; Humans; Male; Middle Aged; Phenoxybenzamine; Physical Examination; Prostat | 1981 |
[Phenoxybenzamine in prostatic pathology. 300 cases (author's transl)].
Topics: Acute Disease; Adrenergic alpha-Antagonists; Humans; Male; Phenoxybenzamine; Placebos; Prostatic Hyp | 1981 |
[Conservative therapy of prostate adenoma with phenoxybenzamine. Clinical aspects and urodynamics].
Topics: Aged; Humans; Male; Middle Aged; Phenoxybenzamine; Prognosis; Prostatic Hyperplasia; Urination Disor | 1981 |
Effects of phenoxybenzamine and prostigmine relative voiding resistance in patients with benign prostatic hypertrophy.
Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Humans; Male; Middle Aged; Neostigmine; Phenoxybenz | 1983 |
Phenoxybenzamine for symptoms of bladder neck obstruction.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; | 1983 |
Phenoxybenzamine in benign prostatic hypertrophy.
Topics: Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia | 1983 |
Phenoxybenzamine and benign prostatic hypertrophy.
Topics: Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; Urodynamics | 1984 |
Alpha-adrenergic blockade in the diagnosis of detrusor instability secondary to infravesical obstruction.
Topics: Aged; Humans; Male; Mechanoreceptors; Middle Aged; Phenoxybenzamine; Prostatic Hyperplasia; Urinary | 1984 |
BPH alpha blocker therapy.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia | 1995 |
Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate.
Topics: Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Epinephrine; Male; Mu | 1993 |
A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. 1978.
Topics: Adrenergic alpha-Antagonists; History, 20th Century; Humans; Male; Phenoxybenzamine; Prostatic Hyper | 2002 |
The use of alpha-adrenergic blockers in benign prostatic obstruction.
Topics: Aged; Humans; Male; Middle Aged; Phenoxybenzamine; Phentolamine; Prostatic Hyperplasia; Urination Di | 1976 |
[Urodynamic study of lower urinary tract. VI. Clinical application of alpha adrenergic blocker for the treatment of benign prostatic hypertrophy and bladder neck contracture (author's transl)].
Topics: Adrenergic alpha-Antagonists; Aged; Contracture; Humans; Male; Middle Aged; Phenoxybenzamine; Prosta | 1978 |
Phenoxybenzamine for benign prostatic hypertrophy.
Topics: Aged; Humans; Male; Middle Aged; Phenoxybenzamine; Prostatic Hyperplasia | 1979 |
Phenoxybenzamine for benign prostatic hypertrophy.
Topics: Dose-Response Relationship, Drug; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia | 1979 |
[Alpha adrenergic blocking agents in disorders of the bladder sphincter].
Topics: Adrenergic alpha-Antagonists; Adult; Female; Humans; Male; Moxisylyte; Nicergoline; Phenoxybenzamine | 1986 |
Medical management of prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aging; Bromocriptine; Cyproterone; Humans; Male; Phenoxybenzamin | 1986 |
Phenoxybenzamine in benign prostatic obstruction.
Topics: Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; Urination | 1988 |
[Therapeutic potentials of the preparation dibenziran in patients with prostatic adenoma].
Topics: Aged; Drug Evaluation; Humans; Male; Middle Aged; Phenoxybenzamine; Prostatic Hyperplasia; Urodynami | 1988 |